Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lauricidin versus petroleum jelly for peri-eyelid application in dry eye and ocular safety
ACTRN12616000011482Phase 2Completed
- Sponsor
- Brien Holden Vision Institute
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of monolaurin and petrolatum in dry eye syndrome (DED) (3 arms), sponsored by Brien Holden Vision Institute. Primary endpoints: Change in eye redness, Change in corneal staining and 1 more. Started Nov 2017; status: completed.
02
Drugs
monolaurinpetrolatum
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on ACTRN12616000011482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616000011482.